Thus, this study demonstrated for the first time the direct association of EGFR and EREG with chronic pain in a clinical cohort of patients and further advocates the use of EREG/EGFR inhibitors as potential analgesics in the management of non-cancer pain in humans. This evidence concerns the gene EGFR and cancer.